These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1055 related items for PubMed ID: 28931568
1. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain. Diaz A, Merino P, Manrique LG, Ospina JP, Cheng L, Wu F, Jeanneret V, Yepes M. J Neurosci; 2017 Oct 25; 37(43):10310-10322. PubMed ID: 28931568 [Abstract] [Full Text] [Related]
2. Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes. Diaz A, Merino P, Manrique LG, Cheng L, Yepes M. J Cereb Blood Flow Metab; 2019 Nov 25; 39(11):2157-2171. PubMed ID: 29890880 [Abstract] [Full Text] [Related]
3. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain. Merino P, Diaz A, Manrique LG, Cheng L, Yepes M. J Biol Chem; 2018 Jun 15; 293(24):9234-9247. PubMed ID: 29720403 [Abstract] [Full Text] [Related]
4. Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke. Wu F, Catano M, Echeverry R, Torre E, Haile WB, An J, Chen C, Cheng L, Nicholson A, Tong FC, Park J, Yepes M. J Neurosci; 2014 Oct 22; 34(43):14219-32. PubMed ID: 25339736 [Abstract] [Full Text] [Related]
5. Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain. Merino P, Yepes M. J Neurol Exp Neurosci; 2018 Oct 22; 4(2):24-29. PubMed ID: 30417161 [Abstract] [Full Text] [Related]
6. Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain. Yepes M. Neural Regen Res; 2020 Apr 22; 15(4):620-624. PubMed ID: 31638083 [Abstract] [Full Text] [Related]
7. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System. Merino P, Diaz A, Jeanneret V, Wu F, Torre E, Cheng L, Yepes M. J Biol Chem; 2017 Feb 17; 292(7):2741-2753. PubMed ID: 27986809 [Abstract] [Full Text] [Related]
8. The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain. Yepes M. Curr Drug Targets; 2019 Feb 17; 20(9):953-959. PubMed ID: 30539695 [Abstract] [Full Text] [Related]
9. Urokinase-type Plasminogen Activator Promotes Synaptic Recovery in the Ischemic Brain. Yepes M. J Transl Neurosci; 2018 Feb 17; 3(2):. PubMed ID: 29938252 [Abstract] [Full Text] [Related]
10. Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain. Merino P, Diaz A, Yepes M. Receptors Clin Investig; 2017 Feb 17; 4(2):. PubMed ID: 28804736 [Abstract] [Full Text] [Related]
11. Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapse. Merino P, Diaz A, Torre ER, Yepes M. J Biol Chem; 2020 Jan 10; 295(2):619-630. PubMed ID: 31819012 [Abstract] [Full Text] [Related]
12. Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage. Diaz A, Merino P, Guo JD, Yepes MA, McCann P, Katta T, Tong EM, Torre E, Rangaraju S, Yepes M. J Neurosci; 2020 May 20; 40(21):4251-4263. PubMed ID: 32332118 [Abstract] [Full Text] [Related]
13. The uPA/uPAR system in astrocytic wound healing. Yepes M. Neural Regen Res; 2022 Nov 20; 17(11):2404-2406. PubMed ID: 35535878 [Abstract] [Full Text] [Related]
14. Plasminogen activator promotes recovery following spinal cord injury. Seeds N, Mikesell S, Vest R, Bugge T, Schaller K, Minor K. Cell Mol Neurobiol; 2011 Aug 20; 31(6):961-7. PubMed ID: 21573723 [Abstract] [Full Text] [Related]
15. Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons. Diaz A, Martin-Jimenez C, Woo Y, Merino P, Torre E, Yepes M. J Alzheimers Dis; 2022 Aug 20; 89(3):877-891. PubMed ID: 35964187 [Abstract] [Full Text] [Related]
16. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching. Semina E, Rubina K, Sysoeva V, Rysenkova K, Klimovich P, Plekhanova O, Tkachuk V. Eur J Cell Biol; 2016 Sep 20; 95(9):295-310. PubMed ID: 27324124 [Abstract] [Full Text] [Related]
17. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Czekay RP, Kuemmel TA, Orlando RA, Farquhar MG. Mol Biol Cell; 2001 May 20; 12(5):1467-79. PubMed ID: 11359936 [Abstract] [Full Text] [Related]
18. Expression and localization of urokinase-type plasminogen activator receptor in bovine cumulus-oocyte complexes. García DC, Miceli DC, Rizo G, García EV, Valdecantos PA, Roldán-Olarte M. Zygote; 2016 Apr 20; 24(2):230-5. PubMed ID: 25939353 [Abstract] [Full Text] [Related]
19. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. Le DM, Besson A, Fogg DK, Choi KS, Waisman DM, Goodyer CG, Rewcastle B, Yong VW. J Neurosci; 2003 May 15; 23(10):4034-43. PubMed ID: 12764090 [Abstract] [Full Text] [Related]
20. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T, Behrendt N, Ploug M. Stem Cells; 1997 May 15; 15(6):398-408. PubMed ID: 9402652 [Abstract] [Full Text] [Related] Page: [Next] [New Search]